Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and efficacy of Androxal in men with secondary hypogonadism has completed; no detailed results are provided in this snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Androxal (enclomiphene citrate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Secondary Hypogonadism | Phase 3 | Status: COMPLETED